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Background: Aging is associated with chronic low-grade inflammatory activity with an elevation of cytokine levels.
An association between regular physical activity and reduction of blood levels of anti-inflammatory cytokines is
demonstrated in the literature pointing to an anti-inflammatory effect related to exercise. However, there is no
consensus regarding which type of exercise and which parameters are the most appropriate to influence
inflammatory markers. Evidence indicates that the single nucleotide polymorphism (SNP) can influence the
synthesis of those cytokines affecting their production.
Methods/Design: The design of this study is a randomized controlled trial. The aim of this study is to investigate
the interaction between the cytokine genes SNP and the effect of physical activity on older women. The main
outcomes are: serum levels of sTNFR-1, sTNFR-2, interleukin (IL)-6, IL-10, measured by the ELISA method; genotyping
of tumor necrosis factor- (TNF)-alpha (rs1800629), IL6 (rs1800795), IL10 (rs1800896) by the TaqMan Method (Applied
Biosystems, Foster City, CA, USA); and physical performance assessed by Timed Up and Go and 10-Meter Walk Tests.
Secondary outcomes include: Geriatric Depression Scale, Perceived Stress Scaleand aerobic capacity, assessed by the
six-minute walk; and lower limb muscle strength, using an isokinetic dinamometer (Biodex Medical Systems, Inc.,
Shirley, NY,USA). Both exercise protocols will be performed three times a week for 10 weeks, 30 sessions in total.
Discussion: Investigating the interaction between genetic factors and exercise effects of both protocols of exercise
on the levels of inflammatory cytokine levels can contribute to guide clinical practice related to treatment and
prevention of functional changes due to chronic inflammatory activity in older adults. This approach could develop
new perspectives on preventive and treatment proposals in physical therapy and in the management of the older
patient.
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Aging is associated with a chronic low-grade inflamma-
tory process characterized by a systemic elevation, from
two to four times, of plasma levels of cytokines as inter-
leukin (IL)-1, tumor necrosis factor alpha (TNF-α), IL-6,
acute phase proteins, soluble TNF receptors (sTNFR)
and IL-10, among others [1]. The balance between pro-
duction and release of those cytokines has been related
to the emergence or aggravation of chronic conditions
related to aging, disability and increased mortality in
olderadults[1,2]. High levels of cytokines are associated
with a reduction of physical performance and muscle
function [3-7]. The underlying mechanism by which
these cytokines contribute to a functional deterioration
in olderadults seems to be their catabolic effect, leading
to a reduction in muscle mass and strength that are
related to sarcopenia [1,8].
TNF-α is an early mediator of inflammation since it
starts and coordinates the acute phase response and
induces the production of a second wave of cytokine ex-
pression, such as IL-6, IL-8 and C-reactive protein [9]. It
also stimulates the production of sTNFR that acts as its
natural inhibitor; therefore, regulating its biological func-
tion. Since these receptors are more stable molecules
than TNF-α in circulation, they are more reliable mar-
kers of plasma TNF-α levels, and hence of the inflamma-
tory response [10]. A few authors argue that TNF-α is
behind the age-related inflammatory changes [11,12],
being associated with the development of insulin resist-
ance and metabolic syndrome [13], and also with reduc-
tion of muscle mass and strength loss due to its
catabolic action [14].
IL-6 is a cytokine that has both pro- and anti-
inflammatory roles and is involved in controlling and co-
ordinating inflammatory responses. It is produced by dif-
ferent cell types, which include the skeletal muscle cells
[15]. On the other hand, IL-10 is an anti-inflammatory
cytokine that is essential to inflammatory activity control
and resolution that is triggered and sustained by other
mediators [16]. The IL-10 inhibitory effect on IL-6 and
TNF-α cytokines is well established in acute inflamma-
tory processes [17], but not in chronic inflammation,
such as we see during aging. The impact of physical
exercises on their plasma levels is not known.
Differences seen in protein expression among people
can occur as a result of functional genetic variations in the
promoter area of these molecules gene [18]. The most
common variations seen on human genomes are the sin-
gle nucleotide polymorphism (SNP). Evidence points that
SNPs, which are present in the genes of several molecules
involved in inflammation, could affect their gene tran-
scription and synthesis [18], modulating the inflammatory
response severity. Some polymorphisms are associated
with a greater production of inflammatory mediators.Thus, gene variations could explain in part the variability
in the production of cytokines, and the greater liability of
certain people to clinical conditions that are mediated by
the elevation of these markers’ production, such as
chronic conditions related to aging and longevity [19-21].
The expression of TNF-α, IL-6 and IL-10 is influ-
enced by functional polymorphisms at their promoter
areas. The polymorphisms in TNF-α (rs1800629), IL-6
(rs1800795) and IL-10 (rs1800896) have been asso-
ciated with several acute and chronic diseases and
with longevity as well [1,19,22]. For instance, Ober-
bach et al. [22] identified that changes in the IL-6
plasma levels in response to exercise were influenced
by the -174 G/C polymorphism, suggesting that genetic
factors related to cytokine production could be determin-
ant to individual effects of the anti-inflammatory response
promoted by exercise. However, literature presents contra-
dictory results related to their activity and effects on
plasma levels of these mediators, especially considering
the older population. One possibility is that differences
shown in the literature are due to interactions between
lifestyle and gene factors, along with cultural and ethnic
differences of the different studied samples.
Observational studies have pointed out that physic-
ally active people have lower concentrations of in-
flammatory cytokines, suggesting that regular exercise
may alleviate the chronic inflammatory activity asso-
ciated with aging [15,23,24]. Consistent evidence has
demonstrated that physical activity induces an eleva-
tion of anti-inflammatory cytokine systemic levels
[25-27], with the skeletal muscle tissue being indi-
cated as an endocrine organ that produces and re-
leases cytokines called miokines [15].
The production and release of IL-6 during physical ac-
tivity seem to rely on factors such as type, intensity and
duration of exercise [26]. Despite the possible benefits of
physical exercise on chronic inflammatory process, in-
formation about the parameters of the ideal exercises for
regulating cytokines have not been established [28-31],
with research results being conflicting.
Therefore, the primary objective of this clinical trial is
to investigate the existence of an interaction among
TNF-α rs1800629, IL6 rs1800795, IL10 rs1800896 and




This study is a randomized controlled trial for which
community-dwellingolder women will be recruited and
randomly assigned to either one of the following phys-
ical activity protocol: muscle strengthening exercises
(MSE) or aerobic exercises (AE). Participants will be
recruited from the community through publicity in local
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The study will be conducted at the Universidade Federal
de Minas Gerais, Belo Horizonte, Brazil.
After the initial evaluation, participants will be rando-
mized into either the MSE or AE group. Randomization
will be performed by means of sealed brown envelopes
without identification. The researcher responsible for
the evaluations will be blinded to the participants’ group.
The study was approved by the Ethics Committee of
Universidade Federal de Minas Gerais (ETIC 038/2010)
and all volunteers will give their written informed con-




Community-dwellingolder women who are sedentary
and aged 65 years or more will be included in the study.
Sedentary older women are those who have not prac-
ticed any regular physical activity (that is, at least three
times a week, 40 minutes minimum) in the last three
months.
Exclusion criteria
Older people with cognitive impairment detectable by
the Mini Mental State Examination [32], acute phase in-
flammatory disease, a history of cancer, current use of
immunomodulatory medications, amputation or lower
limb fracture in the last six months, presence of neuro-
logical sequelae or current participation in an alternative
exercise program will be excluded from the study.
Baseline assessment
A standardized questionnaire will be applied by trained
researchers to collect sample characteristics, socio-
demographic data and information on the clinical condi-
tion of older adults.
Primary outcome measure
1. Plasma levels of TNF-α, sTNFR-1, sTNFR-2, IL-6,
IL-10: 5 ml of blood will be withdrawn from the
participants and immediately centrifuged at
1,500 rpm to obtain plasma. Aliquots will be
removed in a laminar flow hood and stored at
−80 °C. Plasma levels of cytokines will be
determined by ELISA (enzyme-linked
immunosorbent assay) method with high sensitivity
kits (QuantikineWHS, R&D Systems, Minneapolis,
MN, USA). According to the manufacturer the
detection level of the method was 5 pg/ml for
TNFRs, 0.15 pg/ml for IL-6 e 0.75 pg/ml for IL-10.
2. Genotyping – Blood samples will be obtained from
all individuals in ethylenediaminetetraacetic acid(EDTA) anti-coagulant and genomic DNA will be
extracted using a phenol-chloroform method from
unfractionated whole blood, and stored at −20 °C.
TaqMan genotyping assays will be obtained from
Applied Biosystems, Inc. (Foster City, CA, USA).
The assay identification code for each respective
SNP is IL-10 (rs1800896), TNF (rs1800629). A
customized assay will be used for the IL-6 SNP gene.
All amplifications will be carried out in an ABI
7900HT thermal cycler (Applied Biosystems, Inc.)
using TaqMan Genotyping Master Mix and
following the manufacturer's recommended
amplification conditions.
3. Physical Performance will be assessed by means of
Timed Up and Go (TUG) [33] test and the 10-
Meter Walk Test (10MWT) [34]. These tests will be
used because they have demonstrated high reliability
and are commonly used to assess function in older
people. The TUG measures, in seconds, the time
taken to stand up from a standard chair, walk a
distance of three meters, turn, walk back to the
chair and sit down. The TUG score demonstrates
high inter-rater and intra-rater reliability (intraclass
correlation coefficients (ICCs) 0.99 and 0.99
respectively) [35]. The 10MWT has good reliability
(ICC= 0.78 e ICC= 0.93), and is a good marker for
mobility and fall risk [36].
Secondary outcome measure
1. Muscle strength will be assessed using a BiodexW
System 3 Pro isokinetic dynamometer (Biodex
Medical Systems Inc., Shirley, NY,USA). This
instrument has been accepted as the “gold standard”
for assessment of muscular performance [37]. The
muscle groups assessed will be the knee joint
extensors and flexors of the dominant limb at
angular speeds of 60° and 180° in concentric
contractions, with 5 and 15 repetitions respectively,
at intervals of 30 seconds between each velocity. All
procedures will be performed according to the
assessment protocol suggested by the manufacturer,
such as positioning of the volunteer, calibration,
correction for gravity, familiarization and strong
verbal encouragement. Variables chosen for analysis
are work normalized by body mass (%) at 60°, and
Power at 180°.
2. Aerobic capacity, as measured by the 6-Minute
Walk Test (6MWT). The 6MWT has been used in
patients who have different disorders, such as
neurological, cardiothoracic, infant or rheumatologic
dysfunctions, and its correlation with maximum
aerobic capacity is considered to be satisfactory
[38,39]. Data related to systemic blood pressure,
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the Borg scale will be recorded.
3. Geriatric Depression Scale (GDS) is a screen for the
presence of depression in older people. It comprises
15 individual questions; the cut-off-points will be 5/6
(non-case/case) [40,41].
4. The level of stress will be assessed by the 14-item
Perceived Stress Scale validated for Brazilian older
persons. This scale assesses three factors considered
to be keys in the experience of stress: how the
subject evaluates his life as unpredictable,
uncontrollable and overloaded [42].
The salivary cortisol level will be measured as an ob-
jective measurement of stress [42]. The salivary cortisol
level will be collected with cortisol specific Salivette
tubes (Sarstedt.Salivette-swab). The dosage of the saliv-
ary levels will be performed using the ELISA method
(Salimetrics).
Intervention
The participants will be divided into two groups:
strengthening exercises (SE) and aerobic exercises (AE)
groups. Both groups will be submitted to a protocol last-
ing 10 weeks, 30 sessions in total, 3 times a week, under
the direct supervision of a physical therapist.
AE protocol
This protocol will consist of aerobic activities, including
a 5-minute warm-up routine, 40 minutes of aerobic
exercises – walking and free weight exercises for both
upper and lower limbs, and a 5-minute cool down
period, as recommended by the American College of
Sports Medicine [43]. Heart rate will be maintained at
60% of age-predicted maximum heart rate during both
warm-up and cool-down periods, and between 65% to
80% levels during the aerobic activity.
Blood pressure and heart rate will be measured at the
beginning and at the end of every session. To ensure the
safety of participants and to guarantee the proper train-
ing zone, each one of them will be monitored by a car-
diac monitor.
SE protocol
This program was based on a previous study (ISRCT-
N62824599) [44] developed by the Pain and Inflamma-
tion in Rehabilitation and Aging Studies Laboratory
(Laboratório de Dor e Inflamação em Reabilitação e
Estudos do Envelhecimento - LADIRE) research group.
The session will consist of a 10-minute walk, followed
by stretching the rectus femoris, psoas, hamstrings and
triceps surae muscles. Strengthening exercises will be
performed for the following movements: hip flexion, ab-
duction, adduction and extension; knee flexion andextension; mini-squat. The load, suitable for each par-
ticipant, will be calculated by one repetition maximum
(1RM) test. Participants will initiate the exercises at 50%
of 1RM, adjusting the load after two weeks (seventh ses-
sion) to 75% of 1RM. The RM will be recalculated for
sessions 13 and 22, and the exercises will be performed
at 75% of the newly established RM. Participants will be
reassessed after 30 sessions.
Sample size
Based on the multivariate linear regression analysis that
will be performed in this study to explore the SNP influ-
ence on the effects of exercise on plasma levels of cyto-
kines and onephysical performance, 140 older adults
need to be included, considering the sample calculation
of (10 x (K + 1), where K is the number of explanatory
variables of the model. The explanatory variables are
age, anthropometric measurements (Body Mass Index
and Waist Circumference), physical activity level, pres-
ence of depression and stress levels (Perceived Stress
Scale and salivary cortisol), TNF-α rs1800629 (AA+AG
versus GG) , IL6 rs1800795 (GG versus CC+GC) , IL10
rs1800896 (GG versus AA+AG), genes polymorphisms.
Statistical analyses
Insight into the sample characterization will be provided
using descriptive statistics, including measures of central
tendency (mean and median) and variability (range and
standard deviation). Violation of Hardy-Weinberg equi-
librium will be tested by the chi-square test.
The Kolmogorov-Smirnov test will be used to verify
the normal distribution of data. The comparison for be-
tween and within groups data will be analyzed using an
analysis of variance (ANOVA). Post hoc testing will be
undertaken with LSD tests.
The multivariate linear regression analysis will be per-
formed to explore the interaction and the effect of poly-
morphisms on the variables: plasma levels of cytokines
and physical performance, considering the genotype of
each investigated.
Statistical analysis will be performed using the Statistical
Package for Social Sciences (SPSS Inc., Chicago, IL, USA),
version 17.0, and α level will be set at .05.
Discussion
The elevation of the plasma inflammatory cytokine levels
has as its main consequences sarcopenia [6,18,19], re-
duction of function and independence of the older adult.
We have previously demonstrated a weak to moderate
negative correlation between high plasma levels of IL-6
and sTNFR-1, and reduced muscle strength and physical
performance in older women [3,4].
Within this context, physical exercise has been pre-
sented as one of the most effective strategies to influence
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crease in plasma levels of inflammatory markers in the
older adult [7,24,29]. However, even though physical ex-
ercise has been widely performed in clinical practice,
there is no consensus on which type of exercise and
what clinical parameters are the most influential on the
inflammatory markers. Thus, the results of this clinical
trial could contribute to the standardization and man-
agement of clinical practice related to prevention and
treatment of functional changes in the older adult.
A series of evidence suggests that the SNP could affect
the production of cytokines, also influencing physical,
cognitive and behavioral performance, and muscle
strength in the olderadult [18,19,22]. We have recently
investigated the effect of the -174 G/C polymorphism of
the IL-6 gene on the plasma IL-6 levels in both commu-
nity dwelling and institutionalized older women. Homo-
zygotes women for the G allele showed high IL-6 levels,
and an interaction between polymorphism and housing
conditions (community/institution) was observed, with a
higher effect of GG genotype on IL-6 levels in the insti-
tutionalized women [45].
The genes involved in the regulation of the chronic in-
flammatory process can contribute not only to the indi-
vidual variability of cytokine production and physical
performance in the older adult, but also to the response
of these variables to physical exercise. Still, it is import-
ant to note that the evaluation of a single cytokine geno-
type without considering its interaction with other
genotypes from different biological markers could lead
us to misinterpretations, as their combined action could
result in different effects. Therefore, analyzing and
understanding the influence of genetic factors on the
effects of different exercise protocols as proposed by this
study may contribute to the development of new per-
spectives on preventive and therapeutic approaches in
physical therapy and in general management of the older
patient. This trial was designed to be reproducible in
both research and clinical environments.
Abbreviations
10MWT: 10-Meter Walk Test; 1RM: one repetition maximum; 6MWT: 6-Minute
Walk Test; AE: aerobic exercises; EDTA: ethylenediaminetetraacetic acid;
ELISA: Enzyme Linked Immunosorbant Assay; GDS: Geriatric Depression Scale;
IL-10: interleukin-10; IL-6: interleukin-6; IL-8: interleukin-8; MSE: muscle
strengthening exercises; SNP: single nucleotide polymorphism;
sTNFR: soluble TNF receptors; TNF-α: tumor necrosis factor alpha; TUG: Timed
Up and Go.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DSP, LSMP, ALT and DAGP will be responsible for the conception and
implementation of the study, as well as for its writing and final corrections.
RCD will help in the implementation and supervision of the study. DMCA
and BZQ will beresponsible for supervision of the intervention. AMA and
DCF will be responsible for the evaluations. DSP, ECCM and BZQ will be
responsible for the molecular genetic studies. ASM and DSP will beresponsible for the immunoassays. DSP, DAGP and FJM will conduct the data
analysis. All authors contributed to and approved the final manuscript.
Acknowledgments
This work was funded by Fapemig (17621/2011) CAPES, CNPq and (Brazil).
Author details
1Department of Physical Therapy, Graduate Program in Rehabilitation
Sciences, School of Physical Education, Physical Therapy and Occupational
Therapy, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
2Department of Internal Medicine, School of Medicine, Universidade Federal
de Minas Gerais (UFMG), Belo Horizonte, Brazil. 3Departamento de
Fisioterapia, Universidade Federal de Minas Gerais / UFMG, Av. Antônio Carlos,
6627, CEP 31270-901, Belo Horizonte, MG, Brazil.
Received: 17 January 2012 Accepted: 4 July 2012
Published: 8 August 2012
References
1. Krabbe KS, Perdersen M, Bruunsgaard H: Inflammatory mediators in the
elderly. Exp Gerontol 2004, 39:687–699.
2. Tiainen K, Hurme M, Hervonen A, Luukkaala T, Jylha M: Inflammatory
markers and physical performance among nonagenarians. J Gerontol A
Biol Sci Med Sci 2010, 65:658–663.
3. Oliveira DM, Narciso FM, Santos ML, Pereira DS, Coelho FM, Dias JM, Pereira
LS: Muscle strength but not functional capacity is associated with
plasma interleukin-6 levels of community-dwelling elderly women. Braz J
Med Biol Res 2008, 41:1148–1153.
4. Pereira LSM, Narciso FMS, Oliveira DMG, Coelho FM, Souza DG, Dias RC:
Correlation between manual muscle strength and interleukin-6 (IL-6)
plasma levels in elderly community-dwelling women. Arch Gerontol
Geriatr 2009, 48:313–316.
5. Brinkley TE, Leng X, Miller ME, Kitzman DW, Pahor M, Berry MJ, Marsh AP,
Kritchevsky SB, Nicklas BJ: Chronic inflammation is associated with low
physical function in older adults across multiple comorbidities. J Gerontol
A Biol Sci Med Sci 2009, 64:455–461.
6. Ferrucci L, Pennix BWJH, Volpato S, Harris TB, Banden-Roche K, Balfour J,
Leveille SG, Fried LP, Guralnik JM: Change in muscle strength explains
accelerated decline of physical function in older women with high
interleukin-6 serum levels. J Am Geriatr Soc 2002, 50:1947–1954.
7. Coelho FM, Pereira DS, Lustosa LP, Silva JP, Dias JM, Dias RC, Queiroz BZ,
Teixeira AL, Teixeira MM, Pereira LS: Physical therapy intervention (PTI)
increases plasma brain-derived neurotrophic factor (BDNF) levels in non-
frail and pre-frail elderly women. Arch Gerontol Geriatr 2012, 54:415–420.
8. Roubenoff R: Physical activity, inflammation, and muscle loss. Nutr Rev
2007, 65:S208–S212.
9. Makhatadze NJ: Tumor necrosis factor locus: genetic organisation and
biological implications. Hum Immunol 1998, 59:571–579.
10. Aderka D, Engelmann H, Shemer-Avni Y, Hornik V, Galil A, Sarov B, Wallach
D: Variation in serum levels of the soluble TNF receptors among healthy
individuals. Lymphokine Cytokine Res 1992, 11:157–159.
11. Roubenoff R: Catabolism of aging: is it an inflammatory process? Curr
Opin Clin Nutr Metab Care 2003, 6:295–299.
12. Bruunsgaard H: Physical activity and modulation of systemic low-level
inflammation. J Leukoc Biol 2005, 78:819–835.
13. Plomgaard P, Nielsen AR, Fischer CP, Mortensen OH, Broholm C, Penkowa
M, Krogh-Madsen R, Erikstrup C, Lindegaard B, Petersen AM, Taudorf S,
Pedersen BK: Associations between insulin resistance and TNF-alpha in
plasma, skeletal muscle and adipose tissue in humans with and without
type 2 diabetes. Diabetologia 2007, 50:2562–2571.
14. Reid MB, Li Y-P: Tumor necrosis factor-α and muscle wasting: a cellular
perspective. Respir Res 2001, 2:269–272.
15. Pedersen BK, Febbraio MA: Muscle as an endocrine organ: focus on
muscle-derived interleukin-6. Physiol Rev 2008, 88:1379–1406.
16. Moore KW, Malefyt RW, Coffman RL: Interleukin-10 and the interleukin-10
receptor. Annu Rev Immunol 2001, 19:683–765.
17. Hempel L, Korholz D, Bonig H: Interleukin-10 directly inhibits the
interleukin-6 production in T-Cells. Scand J Immunol 1995, 41:462–466.
18. Maat MPM, Bladbjerg EM, Hjelmborg JB, Bathum L, Jespersen J, Christensen
K: Genetic influence on inflammation variables in the elderly. Arterioscler
Thromb Vasc Biol 2004, 24:2168–2173.
Pereira et al. Trials 2012, 13:134 Page 6 of 6
http://www.trialsjournal.com/content/13/1/13419. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M,
Cavallone L, Marchegiani F, Olivieri F, Franceschi C, Caruso C: Inflammation,
genetics, and longevity: further studies on the protective effects in men
of IL-10–1082 promoter SNP and its interaction with TNF-alpha −308
promoter SNP. J Med Genet 2003, 40:296–299.
20. Stephens JW, Hurel SJH, Lowe GDO, Rumley A, Humphries SE:
Association between plasma IL-6, the IL-6–174G>C gene variant and
the metabolic syndrome in type 2 diabetes mellitus. Mol Genet Metab
2007, 90:422–428.
21. Di Bona D, Vasto S, Capurso C, Christiansen L, Deiana L, Franceschi C,
Hurme M, Mocchegiani E, Rea M, Lio D, Candore G, Caruso C: Effect of
interleukin-6 polymorphisms on human longevity: a systematic review
and meta-analysis. Ageing Res Rev 2009, 8:36–42.
22. Oberbach A, Lehmann S, Kirsch K, Krist J, Sonnabend M, Linke A, Tonjes A,
Stumvoll M, Bluher M, Kovacs P: Long-term exercise training decreases
interleukin-6 (IL-6) serum levels in subjects with impaired glucose
tolerance: effect of the -174G/C variant in IL-6 gene. Eur J Endocrinol
2008, 159:129–136.
23. Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman A, Kritchevsky SB,
Pahor M, Taaffe DR, Brach J, Rubin S: Physical activity, exercise, and
inflammatory markers in older adults: findings from the health, aging
and body composition study. J Am Geriatr Soc 2004, 52:1098–1104.
24. Kohut ML, McCann DA, Russell DW, Konopka DN, Cunnick JE, Franke WD,
Castillo MC, Reighard AE, Vanderah E: Aerobic exercise, but not flexibility/
resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of
β-blockers, BMI, and psychosocial factors in older adults. Brain Behav
Immun 2006, 20:201–209.
25. Ostrowski K, Schjerling P, Pedersen BK: Physical activity and plasma
interleukin-6 in humans - effect of intensity of exercise. Eur J Appl Physiol
2000, 83:512–515.
26. Petersen AMW, Pedersen BK: The anti-inflammatory effect of exercise. J
Appl Physiol 2005, 98:1154–1162.
27. Mathur N, Pedersen BK: Exercise as a mean to control low-grade systemic
inflammation. Mediators Inflamm 2008, 2008:109502.
28. Nicklas BJ, Hsu FC, Brinkley TJ, Church T, Goodpaster BH, Kritchevsky SB,
Pahor M: Exercise training and plasma C-reactive protein and
interleukin-6 in elderly people. J Am Geriatr Soc 2008, 56:2045–2052.
29. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF: Resistance
exercise decreases skeletal muscle tumor necrosis factor a in frail elderly
humans. FASEB J 2001, 15:475–482.
30. Nicklas BJ, Ambrosius W, Messier SP, Miller GD, Penninx BW, Loeser RF, Palla
S, Bleecker E, Pahor M: Diet-induced weight loss, exercise, and chronic
inflammation in older, obese adults: a randomized controlled clinical
trial. Am J Clin Nutr 2004, 79:544–551.
31. Phillips MD, Flynn MG, McFarlin BK, Stewart LK, Timmerman KL: Resistance
training at eight-repetition maximum reduces the inflammatory milieu
in elderly women. Med Sci Sports Exerc 2010, 42:314–325.
32. Folstein MF, Folstein SE, McHugh PR: Minimental state. A practical method
for grading the cognitive status of patients for the clinician. J Psychiatr
Res 1975, 12:189–198.
33. Podsiadlo D, Richardson S: The timed up & go: a test of basic functional
mobility for frail elderly persons. J Am Geriatr Soc 1991, 39:142–148.
34. Shinkai S, Watanabe S, Kumagai S, Fujiwara Y, Amano H, Yoshida H, Ishizaki
T, Yukawa H, Suzuki T, Shibata H: Walking speed as a good predictor for
the onset of functional dependence in a Japanese rural community
population. Age Ageing 2000, 29:441–446.
35. Bohannon RW: Reference values for the timed up and go test: a
descriptive meta-analysis. J Geriatr Phys Ther 2006, 29:64–68.
36. VanSwearingen JM, Brach JS: Making geriatric assessment work: selecting
useful measures. Phys Ther 2001, 81:1233–1252.
37. Drouin JM, Valovich-mcLeod TC, Shultz SJ, Gansneder BM, Perrin DH:
Reliability and validity of the Biodex system 3 pro isokinetic
dynamometer velocity, torque and position measurements. Eur J Appl
Physiol 2004, 91:22–29.
38. Enright PL: The six-minute walk test. Respir Care 2003, 48:783–785.
39. Solway S, Brooks D, Lacasse Y, Thomas S: A qualitative systematic
overview of the measurement properties of functional walk tests used in
the cardiorespiratory domain. Chest 2001, 119:256–270.
40. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M: Development
and validation of a geriatric depression screening scale: a preliminary
report. J Psychiatr Res 1982, 17:37–49.41. Almeida OP, Almeida SA: Confiabilidade da versão brasileira da Escala de
Depressão em Geriatria (GDS) versão reduzida. Arq Neuropsiquiatr 1999,
57:421–426.
42. Luft CD, Sanches SO, Mazo GZ, Andrade A: Brazilian version of the
Perceived Stress Scale: translation and validation for the elderly. Rev
Saude Publica 2007, 41:606–615.
43. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, Minson CT, Nigg CR,
Salem GJ, Skinner JS: American College of Sports Medicine position stand.
Exercise and physical activity for older adults. Med Sci Sports Exerc 2009,
41:1510–1530.
44. Lustosa LP, Coelho FM, Silva JP, Pereira DS, Parentoni AN, Dias JM, Dias RC,
Pereira LS: The effects of a muscle resistance program on the functional
capacity, knee extensor muscle strength and plasma levels of IL-6 and
TNF-alpha in pre-frail elderly women: a randomized crossover clinical
trial--a study protoco. Trials 2010, 11:82.
45. Pereira DS, Garcia DM, Narciso FM, Santos ML, Dias JM, Queiroz BZ, Souza
ER, Nobrega OT, Pereira LS: Effects of 174G/C polymorphism in the
promoter region of the interleukin-6 gene on plasma IL-6 levels and
muscle strength in elderly women. Braz J Med Biol Res 2011, 44:123–129.
doi:10.1186/1745-6215-13-134
Cite this article as: Pereira et al.: Interaction between cytokine gene
polymorphisms and the effect of physical exercise on clinical and
inflammatory parameters in older women: study protocol for a
randomized controlled trial. Trials 2012 13:134.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
